The GLP-1 ledger that replaced the brand app
A user on semaglutide stopped staring at the scale and built one private sheet across weight, dose, protein, training, and side effects.
Context
Six months on semaglutide, slow weight loss, rising fatigue, no clear sense of whether anything besides the medication was doing work. The pharmacy app showed weight; nothing else lived together.
The shift
They moved out of the app and into one private sheet — weekly dose, weight, waist, daily protein, training sessions, sleep, and a 1–10 nausea score — and asked a long-context AI to read the months together, not the days.
Approach (in shape, not in recipe)
A vendor-neutral ledger that made the trend, the side-effect spikes around dose escalation, and the weeks where protein and training carried the result instead of the drug visible in one view.
What an honest observer would notice
Real downward weight trend separated from week-to-week noise; clear two-week side-effect window after each dose increase; identification of training frequency as the strongest co-driver of body-composition change.
Recommended next